Clinical trials
Phase 1 Gastrointestinal Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 1 |
| IDRX, Inc., a wholly owned subsidiary of GSK, LLC | 1 |
| Technical University of Munich | 1 |
| Themis Bioscience GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 4 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
| Digestive System Diseases | 1 |
| Esophageal Neoplasms | 1 |
| Gastrointestinal Diseases | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Neoplasm Metastasis | 1 |
| Pancreatic Neoplasms | 1 |
| Stomach Neoplasms | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.